HONG KONG – Disaster preparedness isn't a topic that shows up in frequent biopharma discussions or on conference agendas, but the powerful typhoon that hit Taiwan and Mainland China earlier this month – killing at least 34 people, damaging 65,000 homes and leaving more than 4 million homes without power – highlighted the importance of emergency preparedness for companies in the biopharma space, particularly when setting up shop in a country that is regularly assailed by huge storms and occasional earthquakes.